Compares two supportive care approaches for adults with cancer
Compares technology-based and team-based supportive care for adults with cancer.
Key facts
- Who runs it
- Stanford University
- Where
- Birmingham, Duarte, Fresno, Fruitdale, Fullerton, Honolulu, Las Vegas, Los Angeles, Mather, Mobile, Monterey, Palo Alto, Salt Lake City, and San Francisco, United StatesSee the 17 sites
- Trial code
- Registry title
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Status
- Recruiting
- People taking part
- 2,996 people, planned
- Started
- 24 Jun 2022
- Expected to end
- 28 Feb 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Receive technology-based supportive cancer care
- Receive redesigned team-based supportive cancer care
- Record updated
- 30 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults newly diagnosed with a solid tumor cancer, or whose cancer has come back. It compares two ways of delivering supportive cancer care.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Newly diagnosed solid tumor cancer, or the disease has come back (recurrence).
Main reasons for not taking part
- Cannot give consent to the study
- Plans to change oncologist within 12 months
- Works for the practice site
- Expects to move away from the area within 12 months
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease
- Patients must have the ability to understand and willingness to provide verbal consent
- Participants must speak English, Spanish, Chinese, or Vietnamese
Who cannot take part
- Inability to consent to the study
- Plans to change oncologist within 12 months
- Employed by the practice site
- Patients who anticipate moving from the area within 12 months
Where in United States
- University of Alabama at BirminghamBirmingham, United StatesContact: Gabrielle Rocque, MDTaking people
- Beckman Research Institute of City of HopeDuarte, United StatesContact: Finly Zachariah, MDTaking people
- VA Medical Center, FresnoFresno, United StatesContact: Manali I Patel, MD MPH MSTaking people
- Santa Clara Valley Medical CenterFruitdale, United StatesContact: Sangeeta Aggarwal, MDTaking people
- St Jude Heritage Medical GroupFullerton, United StatesContact: David Park, MDTaking people
- Spark M. Matsunaga VA Medical CenterHonolulu, United StatesContact: Manali I Patel, MD MPH MSTaking people
- North Las Vegas VA Medical CenterLas Vegas, United StatesContact: Manali I Patel, MD MPH MSNo longer taking part
- Oncology Institute for Hope and InnovationLos Angeles, United StatesContact: Richy Agajanian, MDTaking people
- Sacramento VA Medical Center - VA Northern California Health Care SystemMather, United StatesContact: Manali I Patel, MD MPH MSNo longer taking part
- University of South AlabamaMobile, United StatesContact: Jennifer Y Pierce, MDTaking people
- Pacific Cancer CareMonterey, United StatesContact: Manali I Patel, MD MPH MSNo longer taking part
- VA Palo AltoPalo Alto, United StatesContact: Manali I Patel, MD MPH MSNo longer taking part
- George E. Wahlen Department of Veterans Affairs Medical CenterSalt Lake City, United StatesContact: Manali I Patel, MD MPH MSTaking people
- Kaiser Foundation Research InstituteSan Francisco, United StatesContact: Raymond Liu, MDTaking people
- University of San FranciscoSan Francisco, United StatesContact: Kim Rhoads, MDTaking people
- Zuckerberg San Francisco GeneralSan Francisco, United StatesContact: Niharika Dixit, MDTaking people
- San Francisco VA Medical CenterSan Francisco, United StatesContact: Manali I Patel, MD MPH MSNo longer taking part
About the trial
What the trial wants to find out
This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.
The 2 groups in the trial
- Technology-based supportive cancer careExisting treatment, for comparison
Patients receive educational materials to assist with advance care planning and symptom management through a technology-based supportive cancer care weekly during months 1-4 and every other week during months 5-12.
Treatment: Receive technology-based supportive cancer care
- Redesigned team-based supportive cancer careTreatment being tested
Patients are paired with a health educator who will discuss the same educational materials from ARM A either in person or by telephone discussions weekly during months 1-4 and every other week during months 5-12.
Treatment: Receive redesigned team-based supportive cancer care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Plain-language title
- Compares two supportive care approaches for adults with cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 30 April 2026